Results 171 to 180 of about 2,475,393 (270)

In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. [PDF]

J Intercult Ethnopharmacol, 2017
Saidu Y, Muhammad SA, Abbas AY, Onu A, Tsado IM, Muhammad L.   +5 more
europepmc   +1 more source

Safety evaluation of a food enzyme containing leucyl aminopeptidase and Xaa‐Pro dipeptidyl‐peptidase activities from the non‐genetically modified Aspergillus sp. strain DAP 19‐109

EFSA Journal, Volume 24, Issue 10, October 2026.
Abstract The food enzyme containing leucyl aminopeptidase (EC 3.4.11.1) and Xaa‐Pro dipeptidyl‐peptidase (EC 3.4.14.11) activities is produced with the non‐genetically modified Aspergillus sp. strain DAP 19‐109 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Cristina Andreoli, Andrea Terron, Andrey Yurkov, Simone Lunardi, Magdalena Andryszkiewicz, Daniele Cavanna, Natalia Kovalkovicova, Yi Liu   +20 more
wiley   +1 more source

GLP-1 Receptor Agonists Versus DPP-4 Inhibitors and Incident Dementia Risk in COVID-19 Survivors with Type 2 Diabetes: A Target Trial Emulation Study. [PDF]

Drug Des Devel Ther
Hung KC, Yu TS, Liu PH, Lai YC, Chen IW.
europepmc   +1 more source

SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a meta-analysis of outcomes. [PDF]

Front Endocrinol (Lausanne)
Fang X, Li R, Liu S, Zou X, Zhong Y, Yang Y.   +5 more
europepmc   +1 more source

Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature. [PDF]

J Dermatol Case Rep, 2014
Attaway A, Mersfelder TL, Vaishnav S, Baker JK.   +3 more
europepmc   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]

In Vivo
Ohyama K, Takahashi T, Akiyama S, Hori Y.   +3 more
europepmc   +1 more source

GLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation. [PDF]

Diabetes Obes Metab
Tang H, Zhang B, Lu Y, Zhou T, Lu Y, Briceño CA, Han J, Chen Y.   +7 more
europepmc   +1 more source

Do the treatment selection factors emphasized in clinical guidelines-Chronic kidney disease, cardiovascular disease, and heart failure-contribute to the risk of urinary tract infections during the administration of sodium-glucose cotransporter-2 inhibitors? [PDF]

J Diabetes Investig
Koinuma T, Yoshida M, Akazawa M.
europepmc   +1 more source

Dipeptidyl Peptidase-4 Inhibitors Associated Heart Failure Events in Adult Patients With Type-2 Diabetes Mellitus Treated With Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Endocrinol Diabetes Metab
Nepal S, Nepal SP.
europepmc   +1 more source

Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure. [PDF]

Diab Vasc Dis Res
Mortada I, Paul K, Chammany M, Abraham Y, Devulapally K, Lee AW, Mansour S, Chatila K, Boyars MC, Jehle D, Blackwell TA, Jneid H.   +11 more
europepmc   +1 more source